Clincosm LogoSign in Get a demo

Skin Microbiome of Chinese Population Cohort Study

Sponsor
Westlake University (Other)
Overall Status
Recruiting
CT.gov ID
NCT05804851
Collaborator
(none)
150
Enrollment
1
Location
27.2
Anticipated Duration (Months)
5.5
Patients Per Site Per Month

Study Details

Study Description

Brief Summary

This observational study aims to investigate the relationship between public health and the skin microbiome in the province of Zhejiang. Due to the lack of current research on the skin microbiome, the following general questions will be investigated in this study: 1) What connection exists between dietary practices and facial skin microbiome? 2) How do people's lifestyle routines affect the facial skin microbiome? 3) What effects does the altered living environment have on people's facial skin microbiomes? 4) How do the seasons affect people's facial skin microbiomes?

Every 3 to 4 months, the participants' facial skin microbiota samples will be taken, and they will be asked to complete a survey.

Condition or Disease Intervention/Treatment Phase

    Study Design

    Study Type:
    Observational [Patient Registry]
    Anticipated Enrollment :
    150 participants
    Observational Model:
    Cohort
    Time Perspective:
    Prospective
    Official Title:
    Skin Microbiome of Chinese Population Cohort Study: Association Between Human Health and Skin Microbiome
    Anticipated Study Start Date :
    Apr 1, 2023
    Anticipated Primary Completion Date :
    Jul 7, 2025
    Anticipated Study Completion Date :
    Jul 7, 2025

    Outcome Measures

    Primary Outcome Measures

    1. Changes in facial microbiota profiling [Day 1, Day 90, Day 180, Day 270, and Day 360]

      Quantitative and qualitative analysis of bacteria population from the sample, rRNA and metagenome sequencing will be conducted on each sample

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    15 Years to 50 Years
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    Yes
    Inclusion Criteria:
    • ages from 15 to 50.
    Exclusion Criteria:

    • a severe medical history, including a history of surgery or medication, or serious illnesses such as cancer, liver disease, kidney disease, or craniocerebral trauma.

    • recent medical treatment (topical antibiotics, corticosteroids, and other anti-inflammatory drugs within 4 weeks, and systemic antibiotics, corticosteroids, and other immunosuppressive drugs within 6 months)

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Westlake University Hangzhou Zhejiang China 310030

    Sponsors and Collaborators

    • Westlake University

    Investigators

    None specified.

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Westlake University
    ClinicalTrials.gov Identifier:
    NCT05804851
    Other Study ID Numbers:
    • 20230103TL001
    First Posted:
    Apr 7, 2023
    Last Update Posted:
    Apr 7, 2023
    Last Verified:
    Feb 1, 2023
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No

    Study Results

    No Results Posted as of Apr 7, 2023